Author:
Barua Souptik,Glantz Namino,Larez Arianna,Bevier Wendy,Sabharwal Ashutosh,Kerr David
Abstract
AbstractIn type 2 diabetes (T2D), the dawn phenomenon is an overnight glucose rise recognized to contribute to overall glycemia and is a potential target for therapeutic intervention. Existing CGM-based approaches do not account for sensor error, which can mask the true extent of the dawn phenomenon. To address this challenge, we developed a probabilistic framework that incorporates sensor error to assign a probability to the occurrence of dawn phenomenon. In contrast, the current approaches label glucose fluctuations as dawn phenomena as a binary yes/no. We compared the proposed probabilistic model with a standard binary model on CGM data from 173 participants (71% female, 87% Hispanic/Latino, 54 ± 12 years, with either a diagnosis of T2D for six months or with an elevated risk of T2D) stratified by HbA1c levels into normal but at risk for T2D, with pre-T2D, or with non-insulin-treated T2D. The probabilistic model revealed a higher dawn phenomenon frequency in T2D [49% (95% CI 37–63%)] compared to pre-T2D [36% (95% CI 31–48%), p = 0.01] and at-risk participants [34% (95% CI 27–39%), p < 0.0001]. While these trends were also found using the binary approach, the probabilistic model identified significantly greater dawn phenomenon frequency than the traditional binary model across all three HbA1c sub-groups (p < 0.0001), indicating its potential to detect the dawn phenomenon earlier across diabetes risk categories.
Funder
National Science Foundation
U.S. Department of Agriculture
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Schmidt, M. I., Hadji-Georgopoulos, A., Rendell, M., Margolis, S. & Kowarski, A. The Dawn phenomenon, an early morning glucose rise: Implications for diabetic intraday blood glucose variation. Diabetes Care 4, 579–585 (1981).
2. Bolli, G. B. & Gerich, J. E. The ‘dawn phenomenon’—A common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. N. Engl. J. Med. 310, 746–750 (1984).
3. Li, C. et al. The dawn phenomenon across the glycemic continuum: Implications for defining dysglycemia. Diabetes Res. Clin. Pract. 166, 108308 (2020).
4. Kruszynska, Y. T. & Home, P. D. Night-time metabolic changes in normal subjects in the absence of the dawn phenomenon. Diabete Metab. 14, 437–442 (1988).
5. Schmidt, M. I., Lin, Q. X., Gwynne, J. T. & Jacobs, S. Fasting early morning rise in peripheral insulin: evidence of the dawn phenomenon in nondiabetes. Diabetes Care 7, 32–35 (1984).